NEWRON PHARMACEUT. EO-20 (NP5) — Defensive Interval Ratio

Latest as of December 2025: 166 days

NEWRON PHARMACEUT. EO-20 (NP5) has a Defensive Interval Ratio of 166 days as of December 2025. Defensive assets of €22.83 Million (cash €-, short-term investments €16.68 Million, receivables €6.16 Million) cover 166 days of daily cash needs of €137.25K/day. See how liquid is NEWRON PHARMACEUT. EO-20's working capital to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

166 days
Days of operational coverage

Defensive Assets

€22.83 Million
Cash + ST Investments + Receivables

Daily Cash Need

€137.25K
Current Liabilities ÷ 365

Current Liabilities

€50.10 Million
EUR

NEWRON PHARMACEUT. EO-20 Defensive Interval Ratio (2005–2025)

This chart shows how NEWRON PHARMACEUT. EO-20's Defensive Interval Ratio has evolved across 17 annual periods from 2005 to 2025. As of December 2025, the ratio stands at 166 days, meaning defensive assets of €22.83 Million can fund 166 days of operations without new revenue. See NP5 equity to assets ratio to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 (2005–2025)

The table below presents the year-by-year Defensive Interval Ratio for NEWRON PHARMACEUT. EO-20 from 2005 to 2025, covering 17 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NEWRON PHARMACEUT. EO-20 (NP5) total market value.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 166 days €22.83 Million €137.25K/day €- €16.68 Million ▼ -537 days
2024 704 days €45.32 Million €64.40K/day €- €2.89 Million ▲ +593 days
2023 111 days €8.79 Million €79.25K/day €- €6.26 Million ▼ -707 days
2022 818 days €11.29 Million €13.81K/day €- €9.35 Million ▼ -269 days
2021 1087 days €10.88 Million €10.01K/day €- €9.57 Million ▼ -219 days
2020 1306 days €24.66 Million €18.88K/day €- €18.04 Million ▲ +76 days
2019 1230 days €18.86 Million €15.33K/day €- €17.11 Million ▼ -209 days
2018 1439 days €17.47 Million €12.14K/day €- €16.23 Million ▼ -144 days
2017 1583 days €20.50 Million €12.95K/day €- €19.44 Million ▲ +1317 days
2016 266 days €4.85 Million €18.21K/day €- €3.52 Million ▼ -78 days
2015 344 days €6.14 Million €17.84K/day €- €4.92 Million ▼ -441 days
2014 785 days €9.66 Million €12.30K/day €- €6.95 Million ▲ +323 days
2013 462 days €7.68 Million €16.63K/day €- €5.46 Million ▲ +283 days
2012 179 days €5.68 Million €31.74K/day €- €3.64 Million ▼ -14 days
2011 192 days €1.49 Million €7.75K/day €- €- ▲ +125 days
2009 68 days €1.60 Million €23.71K/day €- €1.60 Million ▼ -97 days
2005 164 days €2.30 Million €14.02K/day €- €- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)